Tamar Thompson
Director/Board Member en AVIDITY BIOSCIENCES, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Tamar Thompson is currently serving as the Chairman of the Alexion Charitable Foundation.
Additionally, Ms. Thompson holds the position of Independent Director at Catalyst Pharmaceuticals, Inc. since 2023, Independent Director at Avidity Biosciences, Inc. since 2021, and Vice President of US Government Affairs & Policy at Alexion Pharmaceuticals, Inc. since 2019.
Ms. Thompson previously worked at Bristol Myers Squibb Co. as the Head of Federal Executive Branch Strategy from 2015 to 2019.
Ms. Thompson obtained a graduate degree from Trident University International.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AVIDITY BIOSCIENCES INC
-.--% | 15/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Tamar Thompson
| Empresas | Cargo | Inicio |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 11/01/2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2019 |
| CATALYST PHARMACEUTICALS, INC. | Director/Board Member | 25/05/2023 |
| Alexion Charitable Foundation | Chairman | - |
Antiguos cargos conocidos de Tamar Thompson.
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/11/2019 |
Formación de Tamar Thompson.
| Trident University International | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Avidity Biosciences, Inc. | |
| Alexion Charitable Foundation |
- Bolsa de valores
- Insiders
- Tamar Thompson
